0001225208-22-009352.txt : 20220808 0001225208-22-009352.hdr.sgml : 20220808 20220808162325 ACCESSION NUMBER: 0001225208-22-009352 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220804 FILED AS OF DATE: 20220808 DATE AS OF CHANGE: 20220808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wallace Noel R. CENTRAL INDEX KEY: 0001464265 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00644 FILM NUMBER: 221144730 MAIL ADDRESS: STREET 1: C/O COLGATE-PALMOLIVE COMPANY STREET 2: 300 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO CENTRAL INDEX KEY: 0000021665 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 131815595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123102000 MAIL ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml X0306 4 2022-08-04 0000021665 COLGATE PALMOLIVE CO CL 0001464265 Wallace Noel R. C/O COLGATE-PALMOLIVE COMPANY 300 PARK AVENUE NEW YORK NY 10022 1 1 Chairman, President & CEO Common Stock 2022-08-04 4 M 0 51665.0000 72.9900 A 273455.0000 D Common Stock 2022-08-04 4 S 0 51665.0000 81.2716 D 221790.0000 D Common Stock 49738.0000 I By Issuer's 401(k) Plan Trustee Common Stock 52000.0000 I By Spouse Trust Common Stock 335.0000 I By Trust Stock Option (Right to Buy) 72.9900 2022-08-04 4 M 0 51665.0000 0.0000 D 2022-09-08 Common Stock 51665.0000 0.0000 D Exercise of stock options awarded under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. This transaction was effected pursuant to a Rule 10b5-1 trading plan. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $80.83 to $81.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Option became exercisable in one-third increments beginning on the first anniversary of the September 8, 2016 grant date. /s/ Kristine Hutchinson, Attorney-in-Fact 2022-08-08